RU2005459C1 - Method for treating endocrine sterility in women - Google Patents

Abstract

FIELD: medicine. SUBSTANCE: method involves a single intracutaneous injection of pylastin in a dose of 600-900 units into biologically active symmetrical points BM-46 on the 5th- 7th day of menstrual cycle. Pregnancy in 40-50 % of women ensues on the first or second menstrual cycle after a single injection of pylastin thus raising treating efficiency 5-6 times and reducing treatment duration 10-16 times. EFFECT: higher efficiency.

Description

 The invention relates to medicine, namely to gynecology.

 The closest technical solution to the claimed is a method of influencing biologically active points.

 The disadvantage of this method is the need for one or more courses of acupuncture in combination with restorative, physiotherapeutic and other methods, lack of effectiveness.

 The aim of the invention is to reduce treatment time and increase efficiency.

 The method is as follows. A 600–900 EC EC pilastin is injected intradermally once per patient into the biologically active symmetrical points of BM-46 on the 5-7th day of the menstrual cycle.

 PRI me R 1. Patient V., 32 years old. Diagnosis: hypoovarian syndrome as anovulation. Secondary infertility for 6 years.

 Objectively: with ultrasound scanning: the uterus is 5.1x7.0 cm; ovaries: approx. 3.1 x 2.9 cm; a lion. 2.9 x 2.7 cm. The basal temperature is monotonous. Histological examination: endometritis in the phase of late proliferation. On the 6th day of the menstrual cycle, pilastine was treated.

 The ampoule contains 48,000 EC pilastine. The contents of the ampoule were diluted in 8 ml of sterile distilled water, and a solution containing 1 ml of 6000 EC of the preparation was obtained. The skin at the site of two symmetrical points of BM-46 was treated with alcohol, then, using a tuberculin syringe, 0.1 ml of pylastine solution containing 1 ml of 6000 EC was injected into both points intradermally, the so-called "lemon peel" formed at the injection site. The skin at the injection site was treated with iodine. Total in two points the patient received 1200 EU pilastine.

 After treatment with pilastin, ovulation was recorded using functional diagnostics and under ultrasound monitoring on the 16th day of the second cycle, and pregnancy by the fourth menstrual cycle. Side effects of pilastine are not registered.

 PRI me R 2. Patient K., 28 years old. Diagnosis: ovarian hypofunction by type of NLF corpus luteum failure. Primary infertility for 5 years.

Objectively: ultrasound scanning: uterus 5.6 × 7.2 cm; ovaries - without pathology. Basal temperature: gipertermichnaya phase of 5-7 days, the temperature difference of 0.3 ° ^C. Histological study for 2 days before expected menstruation - endometritis secretion in early phase.

 Assigned to treatment with pilastine according to the proposed method 2 days before the expected menstruation. The ampoule contains 48,000 EC pilastine. The contents of the ampoule were resuspended in 5.3 ml of sterile distilled water, 1 ml of the resulting solution contained 900 O EC of pylastine, and 900 EC in a single point volume (0.1 ml).

 The skin at the site of two symmetrical points of BM-46 was treated with alcohol, using a tuberculin syringe, 0.1 ml (900 EC) was injected intradermally at both points, and lemon crusts formed. The skin at the injection site was treated with iodine. Total two-point patient received 1800 EU. After a single injection of pilastine, the dynamics of functional diagnostics tests was noted. The "pupil" phenomenon appeared in the first menstrual cycle, ovulation also occurred in the first menstrual cycle, pregnancy - in the next. Side effects are not marked.

 PRI me R 3. Patient W. 34 years. Diagnosis: hypoevarial syndrome as anovulation. Secondary infertility for 7 years.

 Objectively: ultrasound scanning: uterus 5.8 × 6.0 cm, ovaries: approx. 2.8 × 3.2 cm, lion. 2.6 × 3.0 cm. Basal temperature is monotonous, histological examination - endometritis in the phase of late proliferation.

 Pilastine treatment was prescribed, the contents of the ampoule with the drug were dissolved in 8 ml of sterile distilled water, 6000 ml were contained in 1 ml of the resulting solution, and 600 ml in 0.1 ml of the resulting solution. The skin in place of two symmetrical points was treated with alcohol. 0.2 ml of the prepared pylastin solution was taken into a tuberculin syringe and two symmetrical points of BM-46 were injected intradermally at 600 EC in 0.1 ml. At the injection site, lemon peels formed. The injection site was treated with iodine.

 The onset of ovulation was recorded using functional diagnostics tests and ultrasound monitoring on the 13th day of the cycle. In the same cycle, pregnancy occurred, which ended in time for the birth of a healthy baby. There was no side effect of pilastine. (56) Pepperell R. Dis. Barren marriage. M.: 1986, p. 44-57.

Claims (1)

 METHOD FOR TREATING ENDOCRINE INFERTILITY IN WOMEN by affecting biologically active points, characterized in that, in order to reduce the treatment time, BM 600 are injected with 600 EC of pylastine once intradermally on the 5th - 7th day of the menstrual cycle.